An interesting and biologically plausible pilot study that provides a fairly strong signal that pediatric Long COVID may be associated with impaired microcirculation and increased arterial stiffness🧵
The study builds on earlier adult research suggesting that persistent symptoms after COVID may be linked to capillary loss and endothelial dysfunction.
This was an observational comparative cohort study, not a randomized or interventional trial.
The study included 37 pediatric patients with Long COVID and 46 healthy controls. On average, the patients were evaluated about 206 ± 167 days after a positive test, so often many months after the initial infection.
Most were adolescents. The average age in the LC group was 13.5 years. The most common symptoms were headache, reduced exercise tolerance, fatigue, and shortness of breath.
The patients were recruited from a specialized LC clinic, so they were not a random sample of all children who had COVID. This raises the possibility that the study captured a more symptomatic or more complex subgroup than the average child after infection.
The first method was sublingual SDF imaging, which looks at the tiny blood vessels under the tongue. They measured
MFI = quality of microvascular blood flow
TVD = total vessel density
PPV = proportion of perfused vessels
distribution of vessels by size
The second was EndoPAT, which provides indirect measures of
RHI as a marker of endothelial function
AIx@75 as a marker of arterial stiffness
Microcirculation
Compared with controls, children with Long COVID had
lower MFI
lower TVD
lower PPV
In simple terms, this suggests fewer small vessels and poorer perfusion.
The most pronounced changes were seen in the small vessel compartment, meaning the capillary side of the microcirculation. At the same time, the relative proportion of medium and large vessels was higher, which the authors interpret as a possible redistribution
Small-vessel TVD 4.61 vs 9.53 mm/mm²
small-vessel PPV 4.00% vs 9.21%
proportion of small vessels 29.97% vs 49.08%
Most of these differences were highly statistically significant!
Arterial stiffness
The LC group also had a higher AIx@75, which points to increased arterial stiffness. By contrast, RHI, the marker of endothelial reactivity, did not differ significantly between groups.
So the clearest signal was in microcirculation and arterial stiffness, but not in this particular endothelial function measure.
The differences remained significant even after statistical adjustment for age, BMI, blood pressure, and sex.
What is the significance of the findings in children with shortness of breath?
This is probably the most clinically interesting part of the paper. Children with shortness of breath had an even lower proportion of small vessels than children with Long COVID without dyspnea. The clearest association was mainly with capillary rarefaction.
The study fits well with the hypothesis that Long COVID may be (at least in part) a vascular and microvascular disorder. The authors mention several possible mechanisms
viral persistence or persistence of viral components
post-acute inflammation
autoimmunity
thrombotic processes
endothelial dysfunction
mitochondrial dysfunction
The control group was examined before the pandemic. That helps avoid the problem of unnoticed prior SARS-CoV-2 infection.
One of the key limitations?
No post COVID without Long COVID comparison group. Without that group, it is hard to know whether these vascular changes are truly specific to Long COVID, or whether some of them might occur more broadly after infection.
There was no long-term follow-up. We do not know whether the microcirculatory changes improve, worsen, or resolve over time.
The authors themselves state that impaired microcirculation and increased arterial stiffness may predispose patients to a higher long-term risk, for example of hypertension or atherosclerosis. @szupraha @ZdravkoOnline @adamvojtech86 @adamkova_vera @strakovka
Boever at al., Microcirculatory impairment and increased arterial stiffness in pediatric Long COVID patients. link.springer.com/article/10.100…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
After SARS-CoV-2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19.
A study based on nationwide Swedish registries followed nearly 10 million people🧵
10 mio people aged 3-100 years from January 1, 2020, to November 30, 2022.
The authors divided participants into those without a COVID-19 diagnosis, those with a positive PCR test without hospitalization, and those hospitalized with COVID-19.
Main finding?
After SARS2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19. Among individuals with a positive PCR test who were not hospitalized, the adjusted relative risk was about 1.6 times higher, and among those hospitalized with COVID-19 it was about 5.7 times higher.
For many people, COVID did not end when the infection cleared - it evolved into a longer and far more complicated story.
This paper presents Long COVID as a heterogeneous, multisystem condition that can affect nearly every organ system🧵
This paper is a broad, wide ranging review of Long Covid. @elisaperego78 describes Long COVID as a heterogeneous, multisystem disease that can affect almost the entire body, with effects ranging from subtle or barely noticeable changes to severe disability or even death.
A key point throughout the paper is that this is not just fatigue after a viral illness, but a condition associated with measurable biological abnormalities.
In this cohort of healthcare workers infected with the original SARS2 variant, symptoms were still present even after a median of 47.5 months (!).
Brain fog may persist.
This is a prospective multicenter cohort study from Switzerland🧵
The study was designed in a fairly sensible way. The authors did not automatically treat every complaint as long COVID, but instead compared 24 chronic symptoms between the previously infected group and an uninfected control.
In this way, they identified 13 symptoms that occurred more frequently after prior infection. The most common were fatigue, smell/taste disturbance, so-called brain fog, meaning problems with concentration and cognition.
The study supports concern that long COVID may be associated with an increased risk of mild cognitive impairment, including impairment with features resembling early Alzheimer’s disease🧵
The study examined whether people with long COVID have a higher incidence of mild cognitive impairment (MCI) than people who had COVID without persistent symptoms and than COVID negative controls.
The authors evaluated 260 individuals and used standardized neurological and neuropsychological assessments, with blinded diagnostic evaluation.
A new long COVID paper suggests that, in a subset of patients, the picture may involve circulating microaggregates, impaired capillary flow, and - EBV-related immune activation🧵
A study describes a subgroup of patients who had so called microaggregates in blood, along with stronger T-cell responses to EBV.
The main idea is that, in some patients, long COVID may involve a mix of impaired microcirculation and immune activation linked to latent herpesviruses.
So what are these microaggregates?
The authors describe them as spherical structures around 100-200µm diameter, containing leukocytes and an amorphous core rich in carbohydrate residues. Platelets were also found on their surface.
This Long COVID study feels scary for a reason - it hits an immune axis immunologists already know from HIV, HBV, sepsis, and cancer. That makes the result more biologically plausible, not less🧵
A study looked at women with Long COVID with an ME/CFS phenotype using single-cell RNA sequencing of peripheral blood 12 months after acute COVID. It was a detailed look at which immune cells were present, how many there were, and what state they were in.
The main finding.
The immune system did not look like it had simply settled down after infection. It looked chronically remodeled and dysregulated.
There were fewer naive CD4/CD8 T cells, Tregs, MAIT cells, γδ T cells, and NK cells - and more effector T cells, activated B cells, platelets, and low-density neutrophils.